GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Azenta Inc (LTS:0HQ1) » Definitions » Gross-Profit-to-Asset %

Azenta (LTS:0HQ1) Gross-Profit-to-Asset % : 12.91% (As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Azenta Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Azenta's annualized Gross Profit for the quarter that ended in Mar. 2025 was $263.5 Mil. Azenta's average Total Assets over the quarter that ended in Mar. 2025 was $2,041.6 Mil. Therefore, Azenta's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 was 12.91%.


Azenta Gross-Profit-to-Asset % Historical Data

The historical data trend for Azenta's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Azenta Gross-Profit-to-Asset % Chart

Azenta Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.20 14.43 9.23 7.97 10.56

Azenta Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.01 11.30 12.55 13.27 12.91

Competitive Comparison of Azenta's Gross-Profit-to-Asset %

For the Medical Instruments & Supplies subindustry, Azenta's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Azenta's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Azenta's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Azenta's Gross-Profit-to-Asset % falls into.


;
;

Azenta Gross-Profit-to-Asset % Calculation

Azenta's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Sep. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Sep. 2024 )/( (Total Assets (A: Sep. 2023 )+Total Assets (A: Sep. 2024 ))/ count )
=263.367/( (2885.72+2100.041)/ 2 )
=263.367/2492.8805
=10.56 %

Azenta's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=263.544/( (2041.21+2041.925)/ 2 )
=263.544/2041.5675
=12.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2025) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Azenta Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Azenta's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Azenta Business Description

Traded in Other Exchanges
Address
200 Summit Drive, 6th Floor, Burlington, MA, USA, 01803
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.

Azenta Headlines

No Headlines